Foam Granulation - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Foam Granulation
The authors review developments in wet granulation using a twin-screw extruder.


Pharmaceutical Technology
Volume 37, Issue 3, pp. 68-72

References

1. E.I. Keleb, A. Vermeire, C. Vervaet, and J.P. Remon, Drug Dev. Ind. Pharm. 30 (6) 679-691 (2004).

2. L. Tan, A.J. Carella, Y. Ren, and J.B. Lo, Pharm. Dev. Tech. 16 (4) 302-315 (2011).

3. E.I. Keleb, A. Vermeire, C. Vervaet, and J.P. Remon, Inter. J. Pharm. 239 (1-2) 69-80 (2002).

4. E.I. Keleb, A. Vermeire, C. Vervaet, and J.P. Remon, Inter. J. Pharm. 273 (1-2) 183-194 (2004).

5. D. Djuric and P. Kleinebudde, J. Pharm. Sci. 97 (11) 4934-4942 (2008).

6. M.R. Thompson, S. Weatherley, R.N. Pukadyil, and P.J. Sheskey, Drug Dev. Ind. Pharm. 38 (7) 771-784 (2012).

7. W. Thiele, "Twin-Screw Extrusion and Screw Design," in Pharmaceutical Extrusion Technology, I. Ghebre-Sellassie and C. Martin, Eds. (Marcel Dekker, New York, NY, 2003), pp. 69-98.

8. D. Djuric, et al., Eur. J. Pharm. Biopharm. 71 (1) 155-160 (2009).

9. M.R. Thompson and J. Sun, J. Pharm. Sci. 99 (4) 2090-2103 (2010).

10. R.M. Dhenge, et al., Pow. Tech., DOI: 10.1016/j.powtec.2012.05.045, May 29, 2012.

11. U. Shah, Pharm. Tech. 29 (6) 52-66 (2005).

12. B. Van Melkebeke, C. Vervaet, and J.P. Remon, Inter. J. Pharm. 356 (1-2) 224-230 (2008).

13. N.O. Lindberg, C. Tufvesson, P. Holm, and L. Olbjer, Drug Dev. Ind. Pharm. 14 (13) 1791-1798 (1988).

14. M.R. Thompson, B. Mu, and P.J. Sheskey, Pow. Tech., 228, 339-348 (2012).

15. C.M. Keary and P.J. Sheskey, Drug Dev. Ind. Pharm., 30 (8) 831-845 (2004).

16. M.X.L. Tan, L.S. Wong, K.H. Lum, and K.P. Hapgood, Chem. Eng. Sci., 64 (12) 2826-2836 (2009).

17. M.X.L. Tan and K.P. Hapgood, Pow. Tech., 218, 149-156 (2012).

18. S.L. Cantor, S. Kothari, and O.M.Y. Koo, Pow. Tech., 195, 15-24 (2009).

19. P. Sheskey, C. Keary, D. Clark, and K. Balwinski, Pharm. Tech., 31 (4) 94-108 (2007).

20. M.X.L. Tan and K.P. Hapgood, Chem. Eng. Res. Des. 89 (5) 526-536 (2011).

21. M.X.L. Tan and K.P. Hapgood, Chem. Eng. Sci. 66 (21) 5204-5211 (2011).

Michael R. Thompson* is an associate professor in the Department of Chemical Engineering at McMaster University, Hamilton, Ontario, L8S 4L7, Canada, Tel: 905.525.9140,
, and Paul J. Sheskey is a principal research scientist at Larkin Laboratory, The Dow Chemical Company, Midland, Michigan.

*To whom all correspondence should be addressed.

Submitted: Sept. 6, 2012. Accepted: Sept. 28, 2012.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Source: Pharmaceutical Technology,
Click here